Duopharma Biotech Berhad reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was MYR 167.52 million compared to MYR 181.74 million a year ago. Net income was MYR 12.54 million compared to MYR 16.31 million a year ago. Basic earnings per share from continuing operations was MYR 0.0131 compared to MYR 0.0172 a year ago. Diluted earnings per share from continuing operations was MYR 0.0131 compared to MYR 0.0172 a year ago.
For the six months, sales was MYR 367.99 million compared to MYR 367.68 million a year ago. Net income was MYR 35.17 million compared to MYR 36.6 million a year ago. Basic earnings per share from continuing operations was MYR 0.0368 compared to MYR 0.0388 a year ago. Diluted earnings per share from continuing operations was MYR 0.0368 compared to MYR 0.0388 a year ago.